Evidence map›Paper›PMID 15629761›Full record

ArticleExperimental neurology2005

Truncated N-terminal mutants of SV40 large T antigen as minimal immortalizing agents for CNS cells.

William J Freed, Peisu Zhang, Joseph F Sanchez, Ora Dillon-Carter, Mark Coggiano, Stacie L Errico, Brian D Lewis, Mary Ellen Truckenmiller

Open access · greenAbstract read
In one paragraph

Article in Experimental neurology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

William J FreedCellular Neurobiology Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Baltimore, MD 21224, USA. wfreed@intra.nida.nih.gov
Peisu Zhang
Joseph F Sanchez
Ora Dillon-Carter
Mark Coggiano
Stacie L Errico
Brian D Lewis
Mary Ellen Truckenmiller
National Institutes of Health · USNational Institute on Drug Abuse · US

Funding

IMMORTALIZED CELL LINESZ01DA000410 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI FREED, WILLIAM J · 1998 to 2008
$866k
NIDA NIH HHS Z01 DA000410-08
6 · The paper itself

Abstract

Immortalized central nervous system (CNS) cell lines are useful as in vitro models for innumerable purposes such as elucidating biochemical pathways, studies of effects of drugs, and ultimately, such cells may also be useful for neural transplantation. The SV40 large T (LT) oncoprotein, commonly used for immortalization, interacts with several cell cycle regulatory factors, including binding and inactivating p53 and retinoblastoma family cell-cycle regulators. In an attempt to define the minimal requirements of SV40 T antigen for immortalizing cells of CNS origin, we constructed T155c, encoding the N-terminal 155 amino acids of LT. The p53 binding region is known to reside in the C-terminal region of LT. An additional series of mutants was produced to further narrow the molecular targets for immortalization, and plasmid vectors were constructed for each. In a p53 temperature sensitive cell line model, T64-7B, expression of T155c and all constructs having mutations outside of the first 82 amino acids were capable of overriding cell-cycle block at the non-permissive growth temperature. Several cell lines were produced from fetal rat mesencephalic and cerebral cortical cultures using the T155c construct. The E107K construct contained a mutation in the Rb binding region, but was nonetheless capable of overcoming cell cycle block in T64-7B cell and immortalizing primary cultured cells. Cells immortalized with T155c were often highly dependent on the presence of bFGF for growth. Telomerase activity, telomere length, growth rates, and integrity of the p53 gene in cells immortalized with T155c did not change over 100 population doublings in culture, indicating that cells immortalized with T155c were generally stable during long periods of continuous culture.

Indexed as

AnimalsAntigens, Viral, TumorCell CycleCell DivisionCell Line, TransformedCells, CulturedCell Transformation, ViralCerebral CortexClone CellsFibroblast Growth Factor 2FibroblastsMesencephalonMutagenesis, Site-DirectedPeptide FragmentsRatsRats, Sprague-DawleyAntigens, Viral, TumorFibroblast Growth Factor 2Peptide FragmentsTelomeraseTumor Suppressor Protein p53

Identifiers

PMID15629761
PMCPMC1925051
OpenAlexW2065410688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.